Russia-China Pharmaceutical Cooperation Forum 2026

June 17, 2026

09:30-16:30

Shanghai New International Expo Centre (SNIEC), CPHI China – E1 Hall, M15 Room, (2^nd floor)

2345 Longyang Road, Pudong New Area, Shanghai, China

Market authorization in EAEU | R&D and clinical trial regulations | state tenders | transfer of technologies
第四届中俄医药合作论坛 I 俄罗斯和欧亚联盟药品注册 I 研发和临床试验监管问题 I 国家集采 I 技术转移

Program

Registration is closed

The Pharmaceutical Cooperation Forum 2026 aims to strengthen comprehensive strategic cooperation between China and Russia in the context of conducting clinical trials, market authorization and import and export of medicines. The conference will include, but not limited to: introduction to new marketing opportunities, state tenders, mandatory requirements for drug development, GMP inspections in Russia, regulatory authorities’ perspective on partnerships, and a detailed breakdown of why Eastern Europe has been the top-ranking region for patient enrollment over the past decade.

With the participation of:

Decision makers

С-Suite executives

Pharmaceutical companies

Regulatory authorities

RCPCF Speakers

Eugenia Radkova

Head of MedSci Consulting and Excellence, MD, PhD

OCT

Roman Ivanov

Director of the Scientific Center for Translational Medicine, Vice-Rector for Scientific and Technological Development

Sirius University of Science and Technology

Kirill Kaem

Member of the Skoltech Academic Council

Daniil Parotkin

Head of biotechnological projects,
Medical Department

PROMOMED RUS

Irina Petrova

Director of Clinical Operations

OCT

Jie Li

Chair of the working group of Policy and Regulation, CMAC

RA SVP, Aeira Ltd.

Dr. Gilbert Wen

CEO

Overseas Pharmaceuticals, Ltd.

Vitaliy Omelyanovskiy

General Director

Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation

Alla Trapkova

Deputy Director General

Federal State Budgetary Institution “Scientific Centre for Expert Evaluation of Medicinal Products” of the Ministry of Health of the Russian Federation

Mikhail Tsyferov

President

NPO Petrovax Pharm

Valeriya Lemeshko, PhD

Government Relations & Policy Subchapter Head

Lancet

Roche-Moscow JSC

Oksana Antonova

Head of Business Development

Lancet

RCPCF 2026 Speaker Lineup

IV Annual Eurasian-Chinese Pharmaceutical Cooperation Forum 2026

9:00–10:00

Registration, Welcome Coffee

10:00–11:30
M15

Session 1: Regulatory Cycle of Innovations: Clinical Trials, Registration, HTA, Pricing, and Patient Access – A Dialogue with the Regulator of the Russian Federation and the EAEU

Regulatory aspects of clinical trials and drug registration
GMP/GCP inspections as an element of trust in the manufacturer
Exchange of experience in the field of health technology assessment (HTA)
Pricing practices for innovative and orphan drugs
Criteria and procedures for inclusion in formularies and the drug supply system
Introduction of Russian drugs to the Chinese market; opinion of the Chinese regulator regarding the inclusion of the Russian Federation in MRCTs (Multiregional Clinical Trials) for the purpose of obtaining data for subsequent registration in the EAEU

11:30–12:00
Lobby

Coffee-break

11:40–11:50

Signing of a cooperation agreement between the Russian biopharmaceutical company Nanolek and a pharmaceutical company from China.

12:00–13:00
M15

Session 2: From Deals to Alliances: Case Studies in Cooperation, Clinical Trials, and Market Access

The Russian market through the eyes of a Chinese manufacturer
Case study of conducting clinical trials in Russia: first patients, challenges, specific features
Priority areas for business development of pharmaceutical companies in the Russian Federation and the People's Republic of China
International cooperation: R&D, raw materials, manufacturing localization, exports
Joint R&D, technology transfer, and commercialization of research results

Past conferences overview

Russia-China Pharmaceutical Cooperation Forum 2025

Check out the II Russia-China Pharmaceutical Cooperation Forum 2024 Recap Video to get thrown back to June for a moment. Absolutely unforgetable experience in Shanghai!

Russia-China Pharmaceutical Cooperation Forum 2024

Check out the II Russia-China Pharmaceutical Cooperation Forum 2024 Recap Video to get thrown back to June for a moment. Absolutely unforgetable experience in Shanghai!

Russia-China Pharmaceutical Cooperation Forum 2023

The time for the 2025 China-Russia Pharmaceutical Cooperation Forum is getting closer. While looking forward to this year's feast, let's review the 2023 China-Russia Pharmaceutical Cooperation Forum held in Shanghai on June 20, 2023.

Key Partners and Sponsors

With the participation of:

Platinum Partners, 2026

Partners

Alex Sun

Corporate Strategy,
CStone Pharmaceuticals

Dear organizers,
Thanks for organizing such a wonderful forum. I am writing to you for the slides presented on the forum. Really appreciate it if you could share them.

OCT

It is very, very important to come here, especially because of the high-rank level of speakers and decision makers on the panels. This event will definitely strengthen comprehensive strategic cooperation between businesses in China and Russia within the context of conducting clinical trials, market authorization, import and export of medicines.

Pharma representative

With this forum held successfully, we learned a lot of market information about China and Russia. Thanks for your efforts!

Gabriel Xiao

Sales Manager, Tofflon

This forum is indispensable. it serves as a bridge, converting geopolitical alignments into tangible healthcare solutions, thereby ensuring that both nations enhance their pharmaceutical sovereignty and simultaneously propel global health innovation. the continuation of this forum underscores resilience and strategic foresight within one of the world's most pivotal sectors.

Ava

Imadek

This is Ava from IMADEK, A customized manufacturer of life science automation equipment. Nice to meet you at RCPCF 2023 and have a on-site communication.
Thanks for your great efforts to this successful forum.